CNS DISEASE

Clinical trials for CNS DISEASE explained in plain language.

Never miss a new study

Get alerted when new CNS DISEASE trials appear

Sign up with your email to follow new studies for CNS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Triple-Drug cocktail aims to tackle Hard-to-Treat cancers

Disease control Not yet recruiting

This study tests a combination of three drugs—tislelizumab, bevacizumab, and capecitabine—in people with advanced solid tumors. The trial focuses on two challenging groups: those whose cancers have stopped responding to immunotherapy and those with tumors that have spread to the …

Matched conditions: CNS DISEASE

Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control

Last updated Jul 03, 2026 20:17 UTC

CNS DISEASE

Get alerted when new CNS DISEASE trials appear

Triple-Drug cocktail aims to tackle Hard-to-Treat cancers